Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug June 10, 2024 AutoBot News 0 The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.